IHS Chemical Week

Regions :: Western Europe :: Germany

Boehringer Ingelheim to Invest €50 Million to Build Pilot Plant for New APIs

5:32 AM MDT | June 1, 2012 | Deepti Ramesh

Boehringer Ingelheim (Ingelheim, Germany) says it will build a new pilot plant facility for the production of newly developed active pharmaceutical ingredients (APIs) at the company’s research and development site at Biberach, Germany. The project will involve an investment of over €50 million ($62 million). Construction of the new facility is scheduled for completion in early 2014. With the new facility, Boehringer Ingelheim aims to ensure that the substances from the well-stocked research pipeline, or the supply of innovative compounds, are available...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa